Celldex Receives Breakthrough Status For Brain Cancer Drug Rindopepimut By: TalkMarkets February 24, 2015 at 18:36 PM EST Designated drug is designed to treat a variant of Glioblastoma Multiforme. Read More >> Related Stocks: Celldex Therapeutics